Updates in Treatment of Recurrent Infection

Authors

Tanveer Singh, Rochester Regional HealthFollow
Prabhjot Bedi, Department of Medicine, UPMC East, Monroeville, PA 15146, USA.
Karandeep Bumrah, Department of Medicine, UPMC East, Monroeville, PA 15146, USA.
Jeevandeep Singh, Department of Medicine, Montefiore Medical Center-Wakefield, Bronx, NY 10466, USA.
Manoj Rai, Department of Medicine, Michigan State University, East Lansing, MI 48824, USA.
Susmitha Seelam, Department of Medicine, UPMC East, Monroeville, PA 15146, USA.

Department

Medicine

Document Type

Article

Publication Title

Journal Of Clinical Medicine Research

Abstract

Recurrent infection (CDI) is a perpetual problem that leads to increased economic burden, higher healthcare cost, and significant morbidity and mortality. Its treatment remains a challenge. While various treatment approaches have been attempted with different levels of success, robust data establishing the superiority of one approach over the others is lacking. In this article, we review the current evidence pertaining to conventional pharmacological treatment as well as fecal microbiota transplantation (FMT) as a novel, rapidly emerging treatment modality for recurrent CDI.

First Page

465

Last Page

471

DOI

10.14740/jocmr3854

Volume

11

Issue

7

Publication Date

7-1-2019

PubMed ID

31236163

Recommended Citation

Singh, T., Bedi, P., Bumrah, K., Singh, J., Rai, M., & Seelam, S. (2019). Updates in Treatment of Recurrent Infection. Journal Of Clinical Medicine Research, 11 (7), 465-471. https://doi.org/10.14740/jocmr3854